HATTERAS CREATE SF SPV, LLC
Profile
Company Names
HATTERAS CREATE SF SPV, LLC
Addresses
280 S. MANGUM STREET, SUITE 350, DURHAM, NC 27701
Phone Numbers
919-484-0730
Entity Type:
LIMITED LIABILITY COMPANY
Industry:
INVESTING
Year Incorporated:
2026
State Incorporated:
NORTH CAROLINA
Total Amount Raised:
$736,987.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2026-03-02
$736,987.00
$3,000,000.00
$2,263,013.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN
C.
CRUMPLER
EXECUTIVE OFFICER
MICHAEL
DIAL
EXECUTIVE OFFICER
-
HATTERAS VENTURE ADVISORS VI, LLC
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS
REED
EXECUTIVE OFFICER
SPINEWORKS MEDICAL INC
| SPINEALIGN MEDICAL INC
| VIAMET PHARMACEUTICALS INC
| PHASEBIO PHARMACEUTICALS INC
| TETRALOGIC PHARMACEUTICALS CORP
| HATTERAS VENTURE PARTNERS IV, LP
| VIAMET PHARMACEUTICALS HOLDINGS LLC
| NEUROTRONIK, INC.
| SIDERIS PHARMACEUTICALS, INC.
| COFERON, INC.
| INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
| BLINKBIO, INC.
| HATTERAS VENTURE PARTNERS V, LP
| QPEX BIOPHARMA, INC.
| HATTERAS VENTURE PARTNERS VI, LP
| EMX ROYALTY CORP
| AVIVOMED INC.
| HATTERAS VENTURE PARTNERS VII, LP
| HATTERAS OPPORTUNITY FUND I, LP
| HATTERAS CREATE SF SPV, LLC
CHRISTY
SHAFFER
EXECUTIVE OFFICER
CLINIPACE INC
| EVOAPP, INC.
| CLEARSIDE BIOMEDICAL, INC.
| G-ZERO THERAPEUTICS, INC.
| G1 THERAPEUTICS, INC.
| KINODYN, INC.
| SPYRYX BIOSCIENCES, INC.
| HATTERAS VENTURE PARTNERS V, LP
| GRAYBUG, INC.
| TREFOIL THERAPEUTICS, INC.
| GRAYBUG VISION, INC.
| ARTIZAN BIOSCIENCES, INC.
| PERFUSE THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VI, LP
| AER THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VII, LP
| HATTERAS OPPORTUNITY FUND I, LP
| HATTERAS CREATE SF SPV, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
